World Cancer Day: interview with Janssen's Biljana Naumovic
To mark World Cancer Day, PharmaTimes talks to Janssen's Biljana Naumovic about the current landscape in oncology
4th February 2020
Web Exclusives
Putting the EMA medicines database to effective use
Momentum and vision around IDMP must be maintained in 2020 if standardised medicinal product data is to be of tangible real-world benefit
3rd February 2020
Upskilling sales reps in a data-driven world
Why companies need to upskill sales reps so they can thrive in this new data-driven world
30th January 2020
A smart future
How artificial intelligence (AI) is changing the pharma and biotech industries
23rd January 2020
An effective training strategy for pharma
Cassie Walker considers the role of Certainty Based Marking in developing an effective training strategy for pharma employees
9th January 2020
Understanding customer needs
Most biopharma marketing executives say they don’t know what clients want – it’s time to change that
8th January 2020
Picking a winner
Duncan McKay considers whether the UK picked a winner in cell and gene therapy
7th January 2020
Portfolio management for the life sciences
Susan Dillon and Richard Baderin say taking the time to fully assess a portfolio can reap highly measurable rewards for life sciences companies, and offer advice on the key areas to focus on for both marketed and non-marketed brands.
2nd January 2020
ReshapingPharma
Jim O’Donoghue considers how pharma can build on digital foundations to focus on outcomes
24th December 2019
Labour's policy for the pharma industry
The Labour Party’s election manifesto presents something of a mixed bag for pharmaceutical companies, say Gareth Morgan and Aisling O’Dwyer
10th December 2019
SmartPeople: David Logue
PharmaTimes talks to David Logue, senior vice president of commercial strategy at Veeva
3rd December 2019
Can private GP services benefit patients who can’t afford them?
Jessica Foreman looks at arguments for and against private GP services
27th November 2019
Prepare to engage
After the election, Brexit will finally become real. Pharma must be ready to engage or risks being left behind.
18th November 2019
Removing the barriers
Merck's Maria Rivas discusses findings from the Supporting Women With Cancer report, which reveals some of the challenges associated with screening for cancer in women, and what more could be done to support the earlier detection of cancer and improve chances of survival.
18th November 2019
